Cerus
CERS
#7698
Rank
A$0.54 B
Marketcap
A$2.82
Share price
-9.66%
Change (1 day)
0.91%
Change (1 year)

Cerus (CERS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.23 Billion

According to Cerus's latest financial reports the company's total liabilities are A$0.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cerus - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.23 B9.32%
2023-12-31A$0.21 B-3.61%
2022-12-31A$0.21 B4.89%
2021-12-31A$0.20 B36.97%
2020-12-31A$0.15 B-1.29%
2019-12-31A$0.15 B38.27%
2018-12-31A$0.11 B47.52%
2017-12-31A$75.96 M19.84%
2016-12-31A$63.38 M3.45%
2015-12-31A$61.27 M24.57%
2014-12-31A$49.18 M8.1%
2013-12-31A$45.5 M58.61%
2012-12-31A$28.68 M8.73%
2011-12-31A$26.38 M9.68%
2010-12-31A$24.05 M65.68%
2009-12-31A$14.51 M-21.57%
2008-12-31A$18.51 M-11.66%
2007-12-31A$20.95 M11.28%
2006-12-31A$18.83 M-41.07%
2005-12-31A$31.95 M-69.31%
2004-12-31A$0.10 B17.4%
2003-12-31A$88.7 M197.87%
2002-12-31A$29.77 M-29.33%
2001-12-31A$42.13 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Haemonetics
HAE
A$2.40 B 941.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$3.92 M-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
A$28.79 B 12,370.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$4.93 M-97.86%๐Ÿ‡บ๐Ÿ‡ธ USA